Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis

被引:99
作者
Bhatt, A
Kremer, L
Dai, AZ
Sacchettini, JC
Jacobs, WR
机构
[1] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA
[2] Univ Montpellier 2, CNRS, UMR 5539, Lab Dynam Mol & Interact Membranaires, F-34095 Montpellier, France
[3] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA
关键词
D O I
10.1128/JB.187.22.7596-7606.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Inhibition or inactivation of InhA, a fatty acid synthase II (FASII) enzyme, leads to mycobacterial cell lysis. To determine whether inactivation of other enzymes of the mycolic acid-synthesizing FASII complex also leads to lysis, we characterized the essentiality of two beta-ketoacyl-acyl carrier protein synthases, KasA and KasB, in Mycobacterium smegmatis. Using specialized transduction for allelic exchange, null kasB mutants, but not kasA mutants, could be generated in Mycobacterium smegmatis, suggesting that unlike kasB, kasA is essential. To confirm the essentiality of kasA, and to detail the molecular events that occur following depletion of KasA, we developed CESTET (conditional expression specialized transduction essentiality test), a genetic tool that combines conditional gene expression and specialized transduction. Using CESTET, we were able to generate conditional null inhA and kasA mutants. We studied the effects of depletion of KasA in M. smegmatis using the former strain as a reference. Depletion of either InhA or KasA led to cell lysis, but with different biochemical and morphological events prior to lysis. While InhA depletion led to the induction of an 80-kDa complex containing both KasA and AcpM, the mycobacterial acyl carrier protein, KasA depletion did not induce the same complex. Depletion of either InhA or KasA led to inhibition of alpha and epoxy mycolate biosynthesis and to accumulation of alpha'-mycolates. Furthermore, scanning electron micrographs revealed that KasA depletion resulted in the cell surface having a "crumpled" appearance, in contrast to the blebs observed on InhA depletion. Thus, our studies support the further exploration of KasA as a target for mycobacterial-drug development.
引用
收藏
页码:7596 / 7606
页数:11
相关论文
共 51 条
[1]   The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance [J].
Banerjee, A ;
Sugantino, M ;
Sacchettini, JC ;
Jacobs, WR .
MICROBIOLOGY-SGM, 1998, 144 :2697-2704
[2]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[3]   Specialized transduction:: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M-bovis BCG and M-smegmatis [J].
Bardarov, S ;
Bardarov, S ;
Pavelka, MS ;
Sambandamurthy, V ;
Larsen, M ;
Tufariello, J ;
Chan, J ;
Hatfull, G ;
Jacobs, WR .
MICROBIOLOGY-SGM, 2002, 148 :3007-3017
[4]   Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis [J].
Bardarov, S ;
Kriakov, J ;
Carriere, C ;
Yu, SW ;
Vaamonde, C ;
McAdam, RA ;
Bloom, BR ;
Hatfull, GF ;
Jacobs, WR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10961-10966
[5]   Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis [J].
Betts, JC ;
McLaren, A ;
Lennon, MG ;
Kelly, FM ;
Lukey, PT ;
Blakemore, SJ ;
Duncan, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :2903-2913
[6]  
Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1
[7]   Tetracycline-inducible gene regulation in mycobacteria [J].
Blokpoel, MCJ ;
Murphy, HN ;
O'Toole, R ;
Wiles, S ;
Runn, ESC ;
Stewart, GR ;
Young, DB ;
Robertson, BD .
NUCLEIC ACIDS RESEARCH, 2005, 33 (02) :e22
[8]  
Carriere C, 1997, J CLIN MICROBIOL, V35, P3232
[9]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[10]   The RD1 proteins of Mycobacterium tuberculosis:: expression in Mycobacterium smegmatis and biochemical characterization [J].
Daugelat, S ;
Kowall, J ;
Mattow, J ;
Bumann, D ;
Winter, R ;
Hurwitz, R ;
Kaufmann, SHE .
MICROBES AND INFECTION, 2003, 5 (12) :1082-1095